Regulated necrosis at the crossroads of liver inflammation and cancer development.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Nature reviews: Gastroenterology & hepatology

• Publication date

  2025-11-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41575-025-01147-8PMID 41286030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development

  2025cited by this paper
• Recommendations for robust and reproducible research on ferroptosis

  2025cited by this paper
• Ferroptosis spreads to neighboring cells via plasma membrane contacts

  2025cited by this paper
• Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease via necroptosis-independent pathway

  2025cited by this paper
• Impact of Mlkl or Ripk3 deletion on age-associated liver inflammation, metabolic health, and lifespan

  2025cited by this paper
• Mouse liver assembloids model periportal architecture and biliary fibrosis

  2025cited by this paper
• MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics

  2025cited by this paper
• Targeting GPX4 to Overcome Sorafenib Resistance of Human Hepatocellular Carcinoma by Inducing Ferroptosis

  2025cited by this paper
• MetALD: Clinical aspects, pathophysiology and treatment

  2024cited by this paper
• NAFLD and NASH: etiology, targets and emerging therapies.

  2024cited by this paper
• Notch-Driven Cholangiocarcinogenesis Involves the Hippo Pathway Effector TAZ via METTL3-m6A-YTHDF1

  2024cited by this paper
• Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis

  2024cited by this paper
• Development of caspase-3-selective activity-based probes for PET imaging of apoptosis

  2024cited by this paper
• Mediators of necroptosis: from cell death to metabolic regulation

  2024cited by this paper
• Single-cell spatial multi-omics and deep learning dissect enhancer-driven gene regulatory networks in liver zonation

  2024cited by this paper
• Divergent roles of RIPK3 and MLKL in high-fat diet–induced obesity and MAFLD in mice

  2024cited by this paper
• Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects

  2024cited by this paper
• Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis.

  2024cited by this paper
• Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress

  2024cited by this paper
• Single-cell and spatial transcriptomics characterisation of the immunological landscape in the healthy and PSC human liver.

  2024cited by this paper
• Inflammasomes and their role in PANoptosomes.

  2024cited by this paper
• Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse Model

  2024cited by this paper
• Innate and adaptive immune cell interaction drives inflammasome activation and hepatocyte apoptosis in murine liver injury from immune checkpoint inhibitors

  2024cited by this paper
• Acetaminophen Hepatotoxicity: Paradigm for Understanding Mechanisms of Drug-Induced Liver Injury.

  2024cited by this paper
• A Novel Multi-organ Male Model of Alcohol-induced Acute-on-chronic Liver Failure Reveals NET-mediated Hepatocellular Death, Which is Prevented by RIPK3 Inhibition

  2024cited by this paper
• CPEB4 modulates liver cancer progression by translationally regulating hepcidin expression and sensitivity to ferroptosis

  2024cited by this paper
• Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation

  2024cited by this paper
• Effect of ferroptosis inhibitors in a murine model of acetaminophen‐induced liver injury

  2024cited by this paper
• NINJ1 induces plasma membrane rupture and release of damage-associated molecular pattern molecules during ferroptosis

  2024cited by this paper
• Transplantation of gasdermin pores by extracellular vesicles propagates pyroptosis to bystander cells.

  2024cited by this paper
• Loss of Ninjurin1 alleviates acetaminophen-induced liver injury via enhancing AMPKα-NRF2 pathway.

  2024cited by this paper
• MLKL promotes hepatocarcinogenesis through inhibition of AMPK-mediated autophagy

  2024cited by this paper
• The ferroptosis mediator ACSL4 fails to prevent disease progression in mouse models of MASLD

  2024cited by this paper
• IL-1 Signal Inhibition in Alcohol-Related Hepatitis: a randomised, double-blind, placebo-controlled trial of canakinumab.

  2024cited by this paper
• Alcohol-associated liver disease

  2024cited by this paper
• A PROTAC Augmenter for Photo‐Driven Pyroptosis in Breast Cancer

  2024cited by this paper
• Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

  2024cited by this paper
• Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative review.

  2024cited by this paper
• Gasdermin and MLKL necrotic cell death effectors: Signaling and diseases.

  2024cited by this paper
• Degraders in epigenetic therapy: PROTACs and beyond

  2024cited by this paper
• Randomized-controlled trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.

  2024cited by this paper
• Nano-PROTACs: state of the art and perspectives.

  2024cited by this paper
• A subpopulation of CD146+ macrophages enhances antitumor immunity by activating the NLRP3 inflammasome

  2023cited by this paper
• A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases.

  2023cited by this paper
• Targeting Endothelial Necroptosis Disrupts Profibrotic Endothelial–Hepatic Stellate Cells Crosstalk to Alleviate Liver Fibrosis in Nonalcoholic Steatohepatitis

  2023cited by this paper
• From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors

  2023cited by this paper
• Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis

  2023cited by this paper
• Global burden of Liver Disease: 2023 Update.

  2023cited by this paper
• Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury

  2023cited by this paper
• Artemisitene Alters LPS-Induced Oxidative stress, inflammation and Ferroptosis in Liver Through Nrf2/HO-1 and NF-kB Pathway

  2023cited by this paper
• A necroptosis-independent function of RIPK3 promotes immune dysfunction and prevents control of chronic LCMV infection

  2023cited by this paper
• Receptor-interacting protein 1 and 3 kinase activity are required for high-fat diet induced liver injury in mice

  2023cited by this paper
• Ferroptosis Detection: From Approaches to Applications.

  2023cited by this paper
• Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer

  2023cited by this paper
• NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis

  2023cited by this paper
• Role of immune responses for development of NAFLD-associated liver cancer and prospects for therapeutic modulation.

  2023cited by this paper
• Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease

  2023cited by this paper
• Spatial and single-cell profiling of the metabolome, transcriptome and epigenome of the aging mouse liver

  2023cited by this paper
• The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice

  2023cited by this paper
• Sublethal necroptosis signaling promotes inflammation and liver cancer.

  2023cited by this paper
• Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4.

  2023cited by this paper
• The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

  2023cited by this paper
• A GPX4 non-enzymatic domain and MDM2 targeting peptide PROTAC for acute lymphoid leukemia therapy through ferroptosis induction.

  2023cited by this paper
• Targeting ferroptosis opens new avenues for the development of novel therapeutics

  2023cited by this paper
• Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade

  2023cited by this paper
• RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis

  2023cited by this paper
• Long Noncoding RNA URB1-Antisense RNA 1 (AS1) Suppresses Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving Ferritin Phase Separation.

  2023cited by this paper
• Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression

  2023cited by this paper
• Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation

  2023cited by this paper
• The Ninj1/Dusp1 Axis Contributes to Liver Ischemia Reperfusion Injury by Regulating Macrophage Activation and Neutrophil Infiltration

  2023cited by this paper
• The Multifaceted Roles of Macrophages in NAFLD Pathogenesis

  2023cited by this paper
• A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma

  2023cited by this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review

  2023cited by this paper
• Biomarkers for immunotherapy of hepatocellular carcinoma

  2023cited by this paper
• Metabolic Dysfunction Associated Steatotic Liver Disease: Current Practice, Screening Guidelines and Management in the Primary Care Setting.

  2023cited by this paper
• Hepatic stellate cells activate and avoid death under necroptosis stimuli: Hepatic fibrosis during necroptosis

  2023cited by this paper
• Engineering materials for pyroptosis induction in cancer treatment

  2023cited by this paper
• Primary Hepatocyte Isolation and Cultures: Technical Aspects, Challenges and Advancements

  2023cited by this paper
• Selective induction of programmed cell death using synthetic biology tools.

  2023cited by this paper
• Genetic deletion or pharmacologic inhibition of the Nlrp3 inflammasome did not ameliorate experimental NASH

  2023cited by this paper
• Novel potential pharmacological applications of dimethyl fumarate—an overview and update

  2023cited by this paper
• NLRP3 activation in neutrophils induces lethal autoinflammation, liver inflammation, and fibrosis

  2022cited by this paper
• No Necroptosis in Hepatocytes: The Final Nail in the Coffin?

  2022cited by this paper
• Gut-liver axis: Pathophysiological concepts and clinical implications.

  2022cited by this paper
• Liver Iron Loading in Alcohol-Associated Liver Disease

  2022cited by this paper
• Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine–Induced Acute Liver Failure Through Inhibiting GSK3β–Nrf2–Mediated Hepatocyte Apoptosis and Ferroptosis

  2022cited by this paper
• Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis

  2022cited by this paper
• Gasdermin D Deficiency Does Not Protect Mice from High-Fat Diet-Induced Glucose Intolerance and Adipose Tissue Inflammation

  2022cited by this paper
• RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease

  2022cited by this paper
• Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies.

  2022cited by this paper
• Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma

  2022cited by this paper
• Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy

  2022cited by this paper
• Deficiency of Ninjurin1 attenuates LPS/D‐galactosamine‐induced acute liver failure by reducing TNF‐α‐induced apoptosis in hepatocytes

  2022cited by this paper
• Neutrophil extracellular traps enriched with IL-1β and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis

  2022cited by this paper
• Inhibition of TWEAK/Tnfrsf12a axis protects against acute liver failure by suppressing RIPK1-dependent apoptosis

  2022cited by this paper
• Context-dependent regulation of ferroptosis sensitivity.

  2022cited by this paper
• Mitochondrial control of inflammation

  2022cited by this paper
• Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity

  2022cited by this paper
• Targeting ferroptosis protects against experimental (multi)organ dysfunction and death

  2022cited by this paper
• Copper homeostasis and cuproptosis in health and disease

  2022cited by this paper

• No citing papers are available for this paper.